197 related articles for article (PubMed ID: 26901843)
1. ANXA5: a key to unlock the mystery of the spectrum of placental-mediated pregnancy complications?
Ormesher L; Greer IA
Womens Health (Lond); 2016; 12(2):159-61. PubMed ID: 26901843
[No Abstract] [Full Text] [Related]
2. Clinicoplacental phenotypes vary with gestational age: an analysis by classical and clustering methods.
Stanek J; Biesiada J; Trzeszcz M
Acta Obstet Gynecol Scand; 2014 Apr; 93(4):392-8. PubMed ID: 24506140
[TBL] [Abstract][Full Text] [Related]
3. Preeclampsia and intrauterine growth restriction: placental disorders still not fully understood.
Maršál K
J Perinat Med; 2017 Oct; 45(7):775-777. PubMed ID: 28985185
[No Abstract] [Full Text] [Related]
4. Pathophysiology of ischemic placental disease.
Roberts JM
Semin Perinatol; 2014 Apr; 38(3):139-45. PubMed ID: 24836825
[TBL] [Abstract][Full Text] [Related]
5. Placental development and function in women with a history of placenta-related complications: a systematic review.
Reijnders IF; Mulders AGMGJ; Koster MPH
Acta Obstet Gynecol Scand; 2018 Mar; 97(3):248-257. PubMed ID: 29125627
[TBL] [Abstract][Full Text] [Related]
6. Obstetric outcome after early placental complications.
Jauniaux E; Van Oppenraaij RH; Burton GJ
Curr Opin Obstet Gynecol; 2010 Dec; 22(6):452-7. PubMed ID: 20930630
[TBL] [Abstract][Full Text] [Related]
7. Current controversies in prenatal diagnosis 4: pregnancy complications due to placental vascular disease (pre-eclampsia, FGR): are we ready for prevention?
Cuckle H; von Dadelszen P; Ghidini A
Prenat Diagn; 2013 Jan; 33(1):17-20. PubMed ID: 23172587
[No Abstract] [Full Text] [Related]
8. Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications.
Aranda F; Udry S; Perés Wingeyer S; Amshoff LC; Bogdanova N; Wieacker P; Latino JO; Markoff A; de Larrañaga G
J Assist Reprod Genet; 2018 May; 35(5):921-928. PubMed ID: 29497952
[TBL] [Abstract][Full Text] [Related]
9. Animal Models to Study Placental Development and Function throughout Normal and Dysfunctional Human Pregnancy.
Grigsby PL
Semin Reprod Med; 2016 Jan; 34(1):11-6. PubMed ID: 26752715
[TBL] [Abstract][Full Text] [Related]
10. Assessment of uteroplacental hemodynamics in complicated pregnancy.
Lippert TH; Cloeren SE; Fridrich R
Int J Gynaecol Obstet; 1978-1979; 16(4):274-80. PubMed ID: 35387
[TBL] [Abstract][Full Text] [Related]
11. Placental vascular pathology as a mechanism of disease in pregnancy complications.
Kovo M; Schreiber L; Bar J
Thromb Res; 2013 Jan; 131 Suppl 1():S18-21. PubMed ID: 23452733
[TBL] [Abstract][Full Text] [Related]
12. Second- and third-trimester biochemical and ultrasound markers predictive of ischemic placental disease.
Savasan ZA; Goncalves LF; Bahado-Singh RO
Semin Perinatol; 2014 Apr; 38(3):167-76. PubMed ID: 24836829
[TBL] [Abstract][Full Text] [Related]
13. Stem Cells and Pregnancy Disorders: From Pathological Mechanisms to Therapeutic Horizons.
James JL
Semin Reprod Med; 2016 Jan; 34(1):17-26. PubMed ID: 26696275
[TBL] [Abstract][Full Text] [Related]
14. Maternal fetal/placental interactions and abnormal pregnancy outcomes.
Roberts JM; Von Versen-Hoeynck F
Hypertension; 2007 Jan; 49(1):15-6. PubMed ID: 17116760
[No Abstract] [Full Text] [Related]
15. Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency - The leading cause of preeclampsia.
Sano T; Terai Y; Daimon A; Nunode M; Nagayasu Y; Okamoto A; Fujita D; Hayashi M; Ohmichi M
Placenta; 2018 May; 65():1-6. PubMed ID: 29908636
[TBL] [Abstract][Full Text] [Related]
16. Tracking placental development in health and disease.
Aplin JD; Myers JE; Timms K; Westwood M
Nat Rev Endocrinol; 2020 Sep; 16(9):479-494. PubMed ID: 32601352
[TBL] [Abstract][Full Text] [Related]
17. Maternal diseases associated with abnormal fetal growth.
Resnik R
J Reprod Med; 1978 Nov; 21(5):315-8. PubMed ID: 731624
[No Abstract] [Full Text] [Related]
18. A guide towards pre-pregnancy management of defective implantation and placentation.
Urato AC; Norwitz ER
Best Pract Res Clin Obstet Gynaecol; 2011 Jun; 25(3):367-87. PubMed ID: 21333605
[TBL] [Abstract][Full Text] [Related]
19. Placental apoptosis and adhesion molecules expression in the placenta and the maternal placental bed of pregnancies complicated by fetal growth restriction with and without pre-eclampsia.
Madazli R; Benian A; Ilvan S; Calay Z
J Obstet Gynaecol; 2006 Jan; 26(1):5-10. PubMed ID: 16390700
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of disorders in fetal viability and placental function in complicated pregnancies].
Levinson LL; Lopatchenko OI
Akush Ginekol (Mosk); 1971 Aug; 47(8):29-33. PubMed ID: 5154623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
